SCHEMBL8772163

SCHEMBL8772163

CC(C)(C)[Si](C)(C)OCc1cccc(/C=C/C=C/C=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNB2 O95067 4/20 0.44
CDK1 P06493 4/20 0.44
CDK4 P11802 4/20 0.44
CCNB1 P14635 4/20 0.44
CCND1 P24385 4/20 0.44
CCNB3 Q8WWL7 4/20 0.44
BACE1 P56817 1/20 0.36
MAOA P21397 6/20 0.36
MAOB P27338 6/20 0.36
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33
TRPA1 O75762 1/20 0.33
LMNA P02545 1/20 0.33
ALOX5 P09917 1/20 0.33
MAPK1 P28482 1/20 0.33
IDO1 P14902 2/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
CYP4F2 P78329 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9626381 0.87 BACE1 (0.35) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL4332449 0.84 MAOA (0.47) BACE1MAOAMAOBALDH1A1IDO1
SCHEMBL8772134 0.84 CYP4F2 (0.36) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL20298754 0.82 LCK (0.44) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL8344755 0.81 BACE1 (0.34) CCNB2CDK1CDK4CCNB1CCND1
SCHEMBL8772123 0.80 MAOB (0.43) BACE1MAOAMAOBALDH1A1KDM4E
SCHEMBL8891484 0.80 MAOB (0.43) BACE1MAOAMAOBALDH1A1KDM4E
Alcohol SCHEMBL9337072 0.79 MAOA (0.43) BACE1MAOAMAOBALDH1A1KDM4E
SCHEMBL5871100 0.78 TP53 (0.40) BACE1MAOAMAOBALDH1A1IDO1
SCHEMBL14566164 0.78 ENPP2 (0.40) BACE1MAOAMAOBALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0801061-A2 Leucotrien-B4 derivatives, process for their preparation and their use as medicaments SCHERING AKTIENGESELLSCHAFT (DE) 1997-10-15 EP disclosed
US-5614634-A Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1997-03-25 US disclosed
US-5440044-A Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1995-08-08 US disclosed
EP-0477311-A1 NEW LEUCOTRIENE B 4? DERIVATIVES, METHODS OF PREPARING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT (DE) 1992-04-01 EP disclosed
WO-1991014676-A1 NEW LEUCOTRIENE B4 DERIVATIVES, METHODS OF PREPARING THEM AND THEIR USE AS DRUGS SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1991-10-03 WO disclosed